Apolipoprotein A-I is the main apolipoprotein of HDL and apolipoprotein A-I-based strategies in the treatment of sepsis are presented in Section 8, whereas the modulation of HDL metabolism by targeting HDL-associated enzymes for the treatment of sepsis is discussed in Section 9. This evidence concerns the gene APOA1 and Sepsis.